[How to act when an alpha-blocker is associated with a potent inhibitor of CYP3A4].
Bensalah N, Garcia S, Rose FX, Bedouch P, Conort O, Juste M, Roubille R, Allenet B, Tod M, Charpiat B.
Bensalah N, et al. Among authors: bedouch p.
Prog Urol. 2017 Apr;27(5):275-282. doi: 10.1016/j.purol.2017.02.003. Epub 2017 Mar 30.
Prog Urol. 2017.
PMID: 28365198
Review.
French.